Integrative lipidomic features identify plasma lipid signatures in chronic urticaria

• Published in: Frontiers in immunology Vol. 13; p. 933312
• Main Authors: Li, Jie, Li, Liqiao, Liu, Runqiu, Zhu, Lei, Zhou, Bingjing, Xiao, Yi, Hou, Guixue, Lin, Liang, Chen, Xiang, Peng, Cong
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 28.07.2022
• Subjects: chronic urticaria; glycerophospholipid; Immunology; lipidomic signatures; mast cell; phosphatidylcholine
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2022.933312

Chronic urticaria (CU) is a chronic inflammatory skin disease mainly mediated by mast cells. Lipids exert essential functions in biological processes; however, the role of lipids in CU remains unclear. Nontargeted lipidomics was performed to investigate the differential lipid profiles between CU patients and healthy control (HC) subjects. Functional validation studies were performed in vitro and in vivo including β-hexosaminidase release examination from mast cells and passive cutaneous anaphylaxis (PCA) mouse model. We detected dramatically altered glycerophospholipids in CU patients compared with HCs. Phosphatidylserine (PS), phosphatidylethanolamine (PE), and phosphatidylglycerol (PG) were increased, while phosphatidylcholine (PC) was reduced in CU patients. The reduction in PC was related to a high weekly urticaria activity score (UAS7), while PS was positively associated with the dermatology life quality index (DLQI). We also identified the differential lipid profiles between chronic spontaneous urticaria (CSU), symptomatic dermographism (SD), and CSU coexist with SD. CU patients were classified into two subtypes (subtype 1 and subtype 2) based on consensus clustering of lipid profiling. Compared with patients in subtype 2, patients in subtype 1 had elevated levels of PC (18:0e/18:2) and PE (38:2), and lower urticaria control test (UCT) scores indicated worse clinical efficiency of secondary generation H1 antihistamines treatment. Importantly, we found that supplementation with PC could attenuate IgE-induced immune responses in mast cells. In general, We described the landscape of plasma lipid alterations in CU patients and provided novel insights into the role of PC in mast cells.